Literature DB >> 7074640

Immune status of untreated patients with Hodgkin's disease and prognosis.

M Björkholm, C Wedelin, G Holm, S Ogenstad, B Johansson, H Mellstedt.   

Abstract

In this study of 127 previously untreated adult patients with Hodgkin's disease and 167 age- and sex-matched controls, highly purified blood lymphocytes were studied for E+ receptors; their spontaneous DNA synthesis and that induced by concanavalin A, pokeweed mitogen, or purified protein derivative of tuberculin were measured as incorporation of 14C-thymidine. T-cell counts and the response to mitogens and antigen were significantly decreased in the patients, while the spontaneous lymphocyte activity was increased. Forty-nine patients had died after a mean observation time of 6 years. In these patients, there had been an increase in spontaneous DNA synthesis and a decrease in that induced by mitogens and antigen. These differences also remained significant when patients who died were compared with surviving patients in stages I-II. The 5-year survival rate of "bad immunology" patients was 30% as compared to 80% for the remainder. We suggest that these lymphocyte tests should be considered in an "immunologic staging system," which may give guidance in the future management of patients with Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074640

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  6 in total

1.  Staging laparotomy with splenectomy for Hodgkin's disease: the Stanford experience.

Authors:  M A Taylor; H S Kaplan; T S Nelsen
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

2.  Clinical and laboratory findings in untreated patients with Hodgkin's disease with special reference to age.

Authors:  C Wedelin; M Björkholm; B Johansson; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

3.  Immune functions and the prognosis of patients with solid tumours.

Authors:  E Nordman; I Lehto; A Toivanen
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

4.  Increased luminol-enhanced chemiluminescence of blood monocytes and granulocytes in Hodgkin's disease.

Authors:  O Tullgren; R Giscombe; G Holm; B Johansson; H Mellstedt; M Björkholm
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

5.  Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells.

Authors:  L Bergmann; P S Mitrou; M Demmer-Dieckmann; F T Ruhmann; E Weidmann
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Authors:  C Wiltschke; M Krainer; A C Budinsky; A Berger; C Müller; R Zeillinger; P Speiser; E Kubista; M Eibl; C C Zielinski
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.